# Xi Jinping

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/xi-jinping
Canonical HTML page: https://getbiobrief.com/entity/xi-jinping

## Timeline

- **2030-12-31**: Healthy China 2030 Deadline — Target date for achieving major healthcare and biotech self-sufficiency milestones.
- **2026-03-19**: Official Launch — President Xi Jinping unveils the 15th FYP at the National People's Congress.
- **2025-10-15**: 15th FYP Drafting — Central Committee reviews the initial draft of the 2026-2030 strategic plan.
- **2021**: 14th FYP Implementation — Focus on 'Dual Circulation' and initial biotech innovation pivot.

## Recent coverage (2 stories)

### China's 15th Five-Year Plan: Xi's Vision for Biotech Sovereignty
2026-03-19 15:33:27 · Sentiment: Neutral · Impact: 8/10 · Sources: 2

President Xi Jinping’s 15th Five-Year Plan (2026-2030) positions biotechnology as a cornerstone of "New Quality Productive Forces," prioritizing domestic innovation and supply chain self-sufficiency. This strategic shift aims to decouple China’s life sciences sector from Western dependencies while accelerating the commercialization of cell and gene therapies.
Full story: https://getbiobrief.com/story/china-15th-five-year-plan-biotech-sovereignty

### AI and Digital Diagnostics Modernize Traditional Chinese Medicine for Global Scale
2026-03-09 06:52:17 · Sentiment: Positive · Impact: 7/10 · Sources: 2

Traditional Chinese Medicine (TCM) is undergoing a digital transformation, utilizing AI-assisted acupuncture and digital pulse diagnosis to standardize ancient practices. Supported by China's 'Healthy China 2030' initiative and the 15th Five-Year Plan, these technological advancements aim to provide scientific evidence and global scalability for TCM across 196 countries.
Full story: https://getbiobrief.com/story/ai-digital-diagnostics-tcm-modernization

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.